Showing results (91-100 of 190) with videos related to
Sort By:
Pageof 19
Rheumatology International|April 12, 2018
The Swiss French version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Michael Hofer, Annette von Scheven-Gête, Matthieu Santos, et al.Rheumatology International|April 12, 2018
The Finnish version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Pekka Lahdenne, Kristiina Aalto, Katariina Rebane, et al.Brain Communications|January 8, 2025
A data-driven model of disability progression in progressive multiple sclerosisSara Garbarino, Carmen Tur, Marco Lorenzi, et al.Rheumatology International|April 12, 2018
The Norwegian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Berit Flato, Marite Rygg, Ellen Berit Nordal, et al.Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|May 11, 2017
Three-Dimensional Shape and Surface Features Distinguish Multiple Sclerosis Lesions from Nonspecific White Matter DiseaseBraeden D Newton, Katy Wright, Mandy D Winkler, et al.Stroke|June 27, 2015
Methods of Implementation of Evidence-Based Stroke Care in Europe: European Implementation Score CollaborationAntonio Di Carlo, Francesca Romana Pezzella, Alec Fraser, et al.Rheumatology International|April 12, 2018
The Romanian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Călin Lazăr, Nicolae Iagăru, Constantin Ailioaie, et al.Rheumatology International|April 12, 2018
The Hungarian version of the Juvenile Arthritis Multidimensional Assessment Report (JAMAR)Ilonka Orbán, Tamás Constantin, Beáta Dérfalvi, et al.Frontiers in Immunology|May 13, 2022
Persistence of Unintegrated HIV DNA Associates With Ongoing NK Cell Activation and CD34+DNAM-1brightCXCR4+ Precursor Turnover in Vertically Infected Patients Despite Successful Antiretroviral TreatmentLucia Taramasso, Federica Bozzano, Anna Casabianca, et al.Multiple Sclerosis (Houndmills, Basingstoke, England)|June 27, 2020
Prevalence of disability improvement as a potential outcome for multiple sclerosis trialsAlessio Signori, Giacomo Boffa, Francesca Bovis, et al.Pageof 19